2020
DOI: 10.1002/ange.202011256
|View full text |Cite
|
Sign up to set email alerts
|

Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation

Abstract: (−)‐Finerenone is a nonsteroidal mineralocorticoid receptor antagonist currently in phase III clinical trials for the treatment of chronic kidney disease in type 2 diabetes. It contains an unusual dihydronaphthyridine core. We report a 6‐step synthesis of (−)‐finerenone, which features an enantioselective partial transfer hydrogenation of a naphthyridine using a chiral phosphoric acid catalyst with a Hantzsch ester. The process is complicated by the fact that the naphthyridine exists as a mixture of two atropi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 36 publications
0
4
0
Order By: Relevance
“…In their patent that described the electrochemical process, Bayer inventors noted that pyridine 15 exists as a mixture of two atropisomers due to hindered rotation. , The electrochemical or chemical oxidation of the undesired enantiomer ( R )- 14 leads to an ( R )- 15 :( S )- 15 ratio of about 15:85. Electrochemical reduction of this mixture leads to a similar ( S )- 15 :( R )- 15 ratio, thereby regenerating a high percentage of the undesired ( R )- 14 enantiomer.…”
Section: Enabling Difficult-to-scale Chemistrymentioning
confidence: 99%
“…In their patent that described the electrochemical process, Bayer inventors noted that pyridine 15 exists as a mixture of two atropisomers due to hindered rotation. , The electrochemical or chemical oxidation of the undesired enantiomer ( R )- 14 leads to an ( R )- 15 :( S )- 15 ratio of about 15:85. Electrochemical reduction of this mixture leads to a similar ( S )- 15 :( R )- 15 ratio, thereby regenerating a high percentage of the undesired ( R )- 14 enantiomer.…”
Section: Enabling Difficult-to-scale Chemistrymentioning
confidence: 99%
“…8 For example, ruthenium catalysts with a chiral diamine ligand (Figure 1a , left) promote the highly stereoselective reduction of quinolines, 9 10 11 12 isoquinolines, 13 quinolizidines, 14 benzoxazines, 15 and indoles. 16 17 The hydrogenation of arenes has also been broadly utilized in total syntheses of natural products, 18 19 20 21 further demonstrating the power of this strategy.…”
Section: Table 1 Optimization Of the Selective Hydrogen...mentioning
confidence: 99%
“…27 28 29 For these systems, numerous computational studies have now generated a good mechanistic understanding that permits the stereoselectivity to be rationalized in many cases. 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Consequently, several articles have compiled reaction lists that can be explained by models derived from computational studies. 17 34 , 53 54 55 56 57 However, no comparable catalogue exists for chiral phosphates.…”
Section: Chiral Phosphate Catalysismentioning
confidence: 99%